Study Summary
This trial will test if a new MRI technique can help diagnose and treat patients with heart conditions.
- Cardiovascular Disease
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 2 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Additional 5 minute research MR scan of heart.
1 of 1
Experimental Treatment
240 Total Participants · 1 Treatment Group
Primary Treatment: Cardiac Magnetic Resonance (CMR) imaging techniques · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 90 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is the upper age limit of prospective participants in this study restricted to octogenarians?
"To be accepted into this trial, potential participants must fall between the age range of 18 and 90. On the other hand, 113 clinical trials are recruiting people younger than 18 while 843 target those beyond 65 years old." - Anonymous Online Contributor
Is enrollment presently open for the experiment?
"According to the online resource, clinicaltrials.gov, this medical trial is in progress and has been since June 20th 2014. The page was last updated on November 29th 2022." - Anonymous Online Contributor
Who should be the primary candidates for this experiment?
"This clinical trial admits 240 patients aged 18 to 90 with carditis. For admittance, participants must have one of the following: myocardial ischemia or infarction (group 1), hypertrophic cardiomyopathy (group 2), infiltrative cardiomyopathy (group 3) ,or myocarditis (group 4). Additionally, they must be previously diagnosed and referred for a clinically indicated CMR." - Anonymous Online Contributor
How many individuals are actively engaged in this clinical experiment?
"Yes, the data hosted on clinicaltrials.gov affirms that this research project is presently seeking participants. It was initially published on June 20th 2014 and its last update occurred on November 29th 2022. The trial needs to enlist 240 patients from 1 centre." - Anonymous Online Contributor